��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Efficacy of Rituximab (RTX) in a Population of 13 Patients with Refractory Myasthenia Gravis (rMG)

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 034

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Claude J. Desnuelle, MD (CHU De Nice - Hopital Pasteur2)	No disclosure on file
Angela M. Hawkins, RN (Saint Lukes Health System)	No disclosure on file
	No disclosure on file
Eric Rosenthal, MD (Massachusetts General Hospital)	Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
Emilien Delmont, MD	No disclosure on file